These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


160 related items for PubMed ID: 20197011

  • 1. Relation of the first hypertension-associated event with medication, compliance and persistence in naïve hypertensive patients after initiating monotherapy.
    Mathes J, Kostev K, Gabriel A, Pirk O, Schmieder RE.
    Int J Clin Pharmacol Ther; 2010 Mar; 48(3):173-83. PubMed ID: 20197011
    [Abstract] [Full Text] [Related]

  • 2. Retrospective analysis of real-world efficacy of angiotensin receptor blockers versus other classes of antihypertensive agents in blood pressure management.
    Petrella R, Michailidis P.
    Clin Ther; 2011 Sep; 33(9):1190-203. PubMed ID: 21885126
    [Abstract] [Full Text] [Related]

  • 3. Long-term persistence to mono and combination therapies with angiotensin converting enzymes and angiotensin II receptor blockers in Australia.
    Gadzhanova S, Roughead EE, Bartlett LE.
    Eur J Clin Pharmacol; 2016 Jun; 72(6):765-71. PubMed ID: 26961086
    [Abstract] [Full Text] [Related]

  • 4. Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
    Patel BV, Remigio-Baker RA, Mehta D, Thiebaud P, Frech-Tamas F, Preblick R.
    J Clin Hypertens (Greenwich); 2007 Sep; 9(9):692-700. PubMed ID: 17786070
    [Abstract] [Full Text] [Related]

  • 5. Real-life treatment patterns, compliance, persistence, and medication costs in patients with hypertension in Germany.
    Breitscheidel L, Ehlken B, Kostev K, Oberdiek MS, Sandberg A, Schmieder RE.
    J Med Econ; 2012 Sep; 15(1):155-65. PubMed ID: 22035215
    [Abstract] [Full Text] [Related]

  • 6. Association between cardiovascular outcomes and antihypertensive drug treatment in older women.
    Wassertheil-Smoller S, Psaty B, Greenland P, Oberman A, Kotchen T, Mouton C, Black H, Aragaki A, Trevisan M.
    JAMA; 2004 Dec 15; 292(23):2849-59. PubMed ID: 15598916
    [Abstract] [Full Text] [Related]

  • 7. Persistence with Antihypertensive Medications in Uncomplicated Treatment-Naïve Patients: Effects of Initial Therapeutic Classes.
    Ah YM, Lee JY, Choi YJ, Kim B, Choi KH, Kong J, Oh JM, Shin WG, Lee HY.
    J Korean Med Sci; 2015 Dec 15; 30(12):1800-6. PubMed ID: 26713055
    [Abstract] [Full Text] [Related]

  • 8. Patient satisfaction with antihypertensive therapy.
    Chen K, Chiou CF, Plauschinat CA, Frech F, Harper A, Dubois R.
    J Hum Hypertens; 2005 Oct 15; 19(10):793-9. PubMed ID: 15951740
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Blood pressure reduction, persistence and costs in the evaluation of antihypertensive drug treatment--a review.
    Bramlage P, Hasford J.
    Cardiovasc Diabetol; 2009 Mar 27; 8():18. PubMed ID: 19327149
    [Abstract] [Full Text] [Related]

  • 11. [Influence of compliance on the incidence of cardiovascular events and health costs when using single-pill fixed-dose combinations for the treatment of hypertension].
    Sicras Mainar A, Galera Llorca J, Muñoz Ortí G, Navarro Artieda R.
    Med Clin (Barc); 2011 Feb 26; 136(5):183-91. PubMed ID: 21106209
    [Abstract] [Full Text] [Related]

  • 12. Persistence of treatment and blood pressure control in elderly hypertensive patients treated with different classes of antihypertensive drugs.
    Borghi C, Veronesi M, Dormi A, Prandin MG, Cosentino E, Strocchi E.
    Am J Geriatr Cardiol; 2007 Feb 26; 16(5):280-6. PubMed ID: 17786056
    [Abstract] [Full Text] [Related]

  • 13. Medication adherence and persistence according to different antihypertensive drug classes: A retrospective cohort study of 255,500 patients.
    Schulz M, Krueger K, Schuessel K, Friedland K, Laufs U, Mueller WE, Ude M.
    Int J Cardiol; 2016 Oct 01; 220():668-76. PubMed ID: 27393848
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Cardiovascular Outcomes in Relation to Antihypertensive Medication Use in Women with and Without Cancer: Results from the Women's Health Initiative.
    Reding KW, Aragaki AK, Cheng RK, Barac A, Wassertheil-Smoller S, Chubak J, Limacher MC, Hundley WG, D'Agostino R, Vitolins MZ, Brasky TM, Habel LA, Chow EJ, Jackson RD, Chen C, Morgenroth A, Barrington WE, Banegas M, Barnhart M, Chlebowski RT.
    Oncologist; 2020 Aug 01; 25(8):712-721. PubMed ID: 32250503
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Antihypertensive agents and risk of Parkinson's disease: a nationwide cohort study.
    Lee YC, Lin CH, Wu RM, Lin JW, Chang CH, Lai MS.
    PLoS One; 2014 Aug 01; 9(6):e98961. PubMed ID: 24910980
    [Abstract] [Full Text] [Related]

  • 19. Factors associated with medication adherence and persistence of treatment for hypertension in a Medicaid population.
    Baggarly SA, Kemp RJ, Wang X, Magoun AD.
    Res Social Adm Pharm; 2014 Aug 01; 10(6):e99-e112. PubMed ID: 24731547
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 8.